Specialist support included in the price A personal DOZA specialist guides you throughout the entire course from first consultation to results
In the laboratory, scientists continue to create modifications to the GLP-1 molecule to slow its natural degradation, allowing it to last longer in the body so it can be used as treatment for type 2 diabetes
Mathieu C, Zinman B, Hemmingsson JU, et al
Its primary actions include: Increasing slow-wave (delta) sleep the deepest, most physically restorative sleep stage Modulating corticotropin-releasing hormone (CRH) reducing the HPA axis signalling that keeps cortisol elevated Influencing LH and somatostatin release both relevant to testosterone and growth hormone secretion Antioxidant activity preclinical data suggests DSIP has direct free-radical scavenging properties (3) Thermoregulatory effects potentially lowering basal body temperature in a manner consistent with natural sleep onset The net effect is not sedation
The FDA has not approved any GLP-1 agonist for inflammatory bowel disease
BPC-157 Shelf Life After Reconstitution Approximately 28 days when refrigerated at 2-8C
